Logo image of MPTI

M-TRON INDUSTRIES INC (MPTI) Stock Fundamental Analysis

NYSEARCA:MPTI - NYSE Arca - US55380K1097 - Common Stock - Currency: USD

42  +0.41 (+0.99%)

Fundamental Rating

8

Overall MPTI gets a fundamental rating of 8 out of 10. We evaluated MPTI against 125 industry peers in the Electronic Equipment, Instruments & Components industry. MPTI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. MPTI is growing strongly while it is still valued neutral. This is a good combination! This makes MPTI very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year MPTI was profitable.
In the past year MPTI had a positive cash flow from operations.
MPTI had positive earnings in each of the past 5 years.
In the past 5 years MPTI always reported a positive cash flow from operatings.
MPTI Yearly Net Income VS EBIT VS OCF VS FCFMPTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2M 4M 6M 8M

1.2 Ratios

The Return On Assets of MPTI (20.60%) is better than 96.00% of its industry peers.
With an excellent Return On Equity value of 23.47%, MPTI belongs to the best of the industry, outperforming 91.20% of the companies in the same industry.
MPTI's Return On Invested Capital of 22.81% is amongst the best of the industry. MPTI outperforms 96.00% of its industry peers.
MPTI had an Average Return On Invested Capital over the past 3 years of 18.77%. This is significantly above the industry average of 9.38%.
The last Return On Invested Capital (22.81%) for MPTI is above the 3 year average (18.77%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 20.6%
ROE 23.47%
ROIC 22.81%
ROA(3y)14.87%
ROA(5y)13.08%
ROE(3y)18.16%
ROE(5y)15.86%
ROIC(3y)18.77%
ROIC(5y)16.38%
MPTI Yearly ROA, ROE, ROICMPTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

MPTI has a better Profit Margin (15.39%) than 92.80% of its industry peers.
MPTI's Profit Margin has improved in the last couple of years.
MPTI has a Operating Margin of 19.02%. This is amongst the best in the industry. MPTI outperforms 96.80% of its industry peers.
In the last couple of years the Operating Margin of MPTI has grown nicely.
MPTI has a Gross Margin of 46.02%. This is in the better half of the industry: MPTI outperforms 79.20% of its industry peers.
In the last couple of years the Gross Margin of MPTI has grown nicely.
Industry RankSector Rank
OM 19.02%
PM (TTM) 15.39%
GM 46.02%
OM growth 3Y34.26%
OM growth 5YN/A
PM growth 3Y38.01%
PM growth 5YN/A
GM growth 3Y9.72%
GM growth 5YN/A
MPTI Yearly Profit, Operating, Gross MarginsMPTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MPTI is creating value.
The number of shares outstanding for MPTI has been increased compared to 1 year ago.
MPTI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MPTI Yearly Shares OutstandingMPTI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
MPTI Yearly Total Debt VS Total AssetsMPTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 19.27 indicates that MPTI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 19.27, MPTI belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
There is no outstanding debt for MPTI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 19.27
ROIC/WACC2.55
WACC8.93%
MPTI Yearly LT Debt VS Equity VS FCFMPTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

MPTI has a Current Ratio of 6.66. This indicates that MPTI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.66, MPTI belongs to the best of the industry, outperforming 84.00% of the companies in the same industry.
A Quick Ratio of 4.61 indicates that MPTI has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.61, MPTI belongs to the best of the industry, outperforming 82.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.66
Quick Ratio 4.61
MPTI Yearly Current Assets VS Current LiabilitesMPTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.63% over the past year.
MPTI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 65.87% yearly.
Looking at the last year, MPTI shows a quite strong growth in Revenue. The Revenue has grown by 17.62% in the last year.
Measured over the past years, MPTI shows a very strong growth in Revenue. The Revenue has been growing by 22.45% on average per year.
EPS 1Y (TTM)70.63%
EPS 3Y65.87%
EPS 5YN/A
EPS Q2Q%5.66%
Revenue 1Y (TTM)17.62%
Revenue growth 3Y22.45%
Revenue growth 5YN/A
Sales Q2Q%13.83%

3.2 Future

The Earnings Per Share is expected to grow by 3.76% on average over the next years.
MPTI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.50% yearly.
EPS Next Y2.76%
EPS Next 2Y3.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.37%
Revenue Next 2Y8.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MPTI Yearly Revenue VS EstimatesMPTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
MPTI Yearly EPS VS EstimatesMPTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.38, MPTI is valued correctly.
MPTI's Price/Earnings ratio is rather cheap when compared to the industry. MPTI is cheaper than 88.80% of the companies in the same industry.
MPTI is valuated rather cheaply when we compare the Price/Earnings ratio to 26.98, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 14.45 indicates a correct valuation of MPTI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MPTI indicates a rather cheap valuation: MPTI is cheaper than 87.20% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.49. MPTI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.38
Fwd PE 14.45
MPTI Price Earnings VS Forward Price EarningsMPTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

MPTI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MPTI is cheaper than 85.60% of the companies in the same industry.
73.60% of the companies in the same industry are more expensive than MPTI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.27
EV/EBITDA 10.15
MPTI Per share dataMPTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of MPTI may justify a higher PE ratio.
PEG (NY)5.58
PEG (5Y)N/A
EPS Next 2Y3.76%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MPTI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

M-TRON INDUSTRIES INC

NYSEARCA:MPTI (6/30/2025, 4:10:02 PM)

42

+0.41 (+0.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-12 2025-08-12/amc
Inst Owners35.7%
Inst Owner ChangeN/A
Ins Owners8.82%
Ins Owner Change0.71%
Market Cap122.64M
AnalystsN/A
Price Target68.34 (62.71%)
Short Float %0.85%
Short Ratio0.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.39%
Min EPS beat(2)-16.82%
Max EPS beat(2)-1.96%
EPS beat(4)2
Avg EPS beat(4)12.95%
Min EPS beat(4)-16.82%
Max EPS beat(4)47.06%
EPS beat(8)5
Avg EPS beat(8)15.04%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.33%
Min Revenue beat(2)-3.98%
Max Revenue beat(2)-2.68%
Revenue beat(4)2
Avg Revenue beat(4)0.72%
Min Revenue beat(4)-3.98%
Max Revenue beat(4)6.19%
Revenue beat(8)4
Avg Revenue beat(8)0.93%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.29%
PT rev (3m)-4.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.69%
EPS NY rev (1m)0%
EPS NY rev (3m)13.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.38
Fwd PE 14.45
P/S 2.43
P/FCF 23.27
P/OCF 16.07
P/B 3.7
P/tB 3.7
EV/EBITDA 10.15
EPS(TTM)2.73
EY6.5%
EPS(NY)2.91
Fwd EY6.92%
FCF(TTM)1.8
FCFY4.3%
OCF(TTM)2.61
OCFY6.22%
SpS17.31
BVpS11.35
TBVpS11.34
PEG (NY)5.58
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 20.6%
ROE 23.47%
ROCE 28.98%
ROIC 22.81%
ROICexc 38.76%
ROICexgc 38.84%
OM 19.02%
PM (TTM) 15.39%
GM 46.02%
FCFM 10.42%
ROA(3y)14.87%
ROA(5y)13.08%
ROE(3y)18.16%
ROE(5y)15.86%
ROIC(3y)18.77%
ROIC(5y)16.38%
ROICexc(3y)25.86%
ROICexc(5y)21.61%
ROICexgc(3y)25.95%
ROICexgc(5y)21.75%
ROCE(3y)23.85%
ROCE(5y)20.81%
ROICexcg growth 3Y50.31%
ROICexcg growth 5YN/A
ROICexc growth 3Y50.73%
ROICexc growth 5YN/A
OM growth 3Y34.26%
OM growth 5YN/A
PM growth 3Y38.01%
PM growth 5YN/A
GM growth 3Y9.72%
GM growth 5YN/A
F-Score6
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 236.44%
Cap/Sales 4.67%
Interest Coverage 1603
Cash Conversion 71.88%
Profit Quality 67.74%
Current Ratio 6.66
Quick Ratio 4.61
Altman-Z 19.27
F-Score6
WACC8.93%
ROIC/WACC2.55
Cap/Depr(3y)158.29%
Cap/Depr(5y)152.18%
Cap/Sales(3y)3.31%
Cap/Sales(5y)3.08%
Profit Quality(3y)74.9%
Profit Quality(5y)98.76%
High Growth Momentum
Growth
EPS 1Y (TTM)70.63%
EPS 3Y65.87%
EPS 5YN/A
EPS Q2Q%5.66%
EPS Next Y2.76%
EPS Next 2Y3.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.62%
Revenue growth 3Y22.45%
Revenue growth 5YN/A
Sales Q2Q%13.83%
Revenue Next Year9.37%
Revenue Next 2Y8.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y82.47%
EBIT growth 3Y64.41%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y214.82%
FCF growth 3Y44.57%
FCF growth 5YN/A
OCF growth 1Y207.62%
OCF growth 3Y36.46%
OCF growth 5YN/A